Food and Drug Administration Archives

John SchroyerDecember 11, 2023

The biggest hurdle may be the current Speaker of the House, who has consistently voted against legalization.

John SchroyerAugust 30, 2023

Moving cannabis to Schedule 3 could eliminate the onerous 280E tax provision for operators.

Adam JacksonJuly 28, 2023

The FDA actively declined to regulate CBD as a supplement without action from Congress.

StaffJuly 25, 2023

The Daily Hit is a recap of the top financial news stories for July 25, 2023. On the Site Maryland Hemp Companies Sue State Over Adult-Use Marijuana Rules A group of hemp companies in Maryland have filed suit against the governor and several state officials, claiming that the regulatory plan lawmakers authorized for the recreational […]

StaffJuly 14, 2023

New FDA guidance on psychedelics changes little for researchers but could open minds and funding sources.

StaffJuly 5, 2023

The Daily Hit is a recap of the top financial news stories for July 5, 2023. On the Site MedMen Names New CEO, CFO Embattled marijuana multistate operator MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) announced new company leadership on Wednesday, with former Acreage Holdings executive Ellen Deutsch appointed CEO by the MedMen board of directors, […]

John SchroyerJune 30, 2023

Rescheduling could leave criminal penalties in place for state-licensed recreational cannabis companies.

StaffJune 27, 2023

The Daily Hit is a recap of the top financial news stories for June 27, 2023. On the Site Florida Governor Signs Medical Marijuana Bill Despite Opposition to Federal Reform In the span of just four days, Florida Gov. Ron DeSantis both nixed the possibility of federal marijuana decriminalization if he wins the U.S. presidency and also […]

Adam JacksonJune 27, 2023